MedPath
NMPA Approval

Compound Sulfadiazine Granules

国药准字H13023605

March 2, 2021

国药准字H13023605

Drug Information

复方磺胺嘧啶颗粒

颗粒剂

磺胺嘧啶0.4g,甲氧苄啶50mg

化学药品

March 2, 2021

Company Information

Applicant Company

张家口市宣化县沙岭子镇(东山产业集聚区)

Manufacturing Company

河北省张家口市宣化县沙岭子镇(东山产业集聚区)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方磺胺嘧啶颗粒 - NMPA 批准文号 | MedPath